Idea principal
In 291 adults aged 60 and older with insomnia, 2 months of cognitive behavioral therapy for insomnia (CBT-I) cut incident or recurrent major depression to 12.2% from 25.9% with sleep education therapy (HR 0.51, 95% CI 0.29-0.88, P = .02). The trial was single-site, and follow-up completion was lower in the CBT-I group (73.1% vs 86.7% at 24 months).
Study design
Ensayo aleatorizado
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Older adults with insomnia have a high risk of new and recurrent depression, yet prevention in this age group has been neglected. The authors tested whether treating insomnia disorder with CBT-I prevents major depressive disorder better than an active comparator, sleep education therapy (SET).
Población y método
Assessor-blinded, parallel-group, single-site randomized clinical trial. Of 431 people assessed in the community, 291 adults aged 60 or older with insomnia disorder and no major depression or major health events in the past year were enrolled between July 1, 2012 and April 30, 2015. They were randomized to 2 months of CBT-I (n = 156) or SET (n = 135). The primary outcome was time to incident major depressive disorder by interview and DSM-5 criteria, and a secondary outcome was sustained remission of insomnia. Follow-up was extended from 24 to 36 months, ending July 2018.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Incident or recurrent major depression occurred in 19 participants (12.2%) in the CBT-I group and 35 participants (25.9%) in the SET group (HR 0.51, 95% CI 0.29-0.88, P = .02), with a benefit consistent across subgroups.
- 2Sustained remission of insomnia before a depression event or during follow-up was more likely with CBT-I (41 participants, 26.3%) than SET (26 participants, 19.3%, P = .03).
- 3Participants in the CBT-I group with sustained insomnia remission had an 82.6% decreased likelihood of depression (HR 0.17, 95% CI 0.04-0.73, P = .02) compared with SET participants without sustained remission.
- 4Fewer people completed CBT-I (140, 89.7%) than SET (130, 96.3%, P = .03), and 24-month follow-up was completed by 114 (73.1%) vs 117 (86.7%) (P = .004); at 36 months, 81 (51.9%) vs 77 (57.0%) (P = .39).
Límites e incertidumbre
- 1Many participants did not complete 36 months of follow-up (81 in CBT-I and 77 in SET), and the extension was added after the protocol started, so later outcomes are less certain.
- 2Loss to follow-up was uneven, with more dropouts in the CBT-I group at 24 months, which could bias the comparison.
- 3The trial was at a single site and the sample was 82.8% White, so it may not generalise to other groups or health systems.
- 4The comparison of sustained remission versus no remission is not a randomised comparison, and the confidence interval is wide (0.04-0.73). This reading is based on the abstract only.
Relevancia práctica
For older adults with insomnia, a short course of CBT-I appears to help prevent depression as well as treat sleep, which supports asking about sleep as part of mood care. This is not a reason to stop other treatment, and anyone with low mood or persistent insomnia should talk to their clinician, who can offer CBT-I or similar support.
Tus datos
A sleep tracker's sleep duration, bedtime consistency and awakenings can mirror CBT-I diaries, but nights of poor sleep on a device are not a depression test. Use the same device and focus on multi-week trends in your regular sleep pattern, ideally alongside a sleep diary.
Cómo interpretar la evidencia
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Importance
Older adults with insomnia have a high risk of incident and recurrent depression. Depression prevention is urgently needed, and such efforts have been neglected for older adults.
Objective
To examine whether treatment of insomnia disorder with cognitive behavioral therapy for insomnia (CBT-I) compared with an active comparator condition, sleep education therapy (SET), prevents major depressive disorder in older adults.
Design, setting, and participants
This assessor-blinded, parallel-group, single-site randomized clinical trial assessed a community-based sample of 431 people and enrolled 291 adults 60 years or older with insomnia disorder who had no major depression or major health events in past year. Study recruitment was performed from July 1, 2012, to April 30, 2015. The trial protocol was modified to extend follow-up from 24 to 36 months, with follow-up completion in July 2018. Data analysis was performed from March 1, 2019, to March 30, 2020.
Interventions
Participants were randomized to 2 months of CBT-I (n = 156) or SET (n = 135).
Main outcomes and measures
The primary outcome was time to incident major depressive disorder as diagnosed by interview and Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) criteria. Secondary outcome was sustained remission of insomnia disorder before depression event or duration of follow-up.
Results
Among 291 randomized participants (mean [SD] age, 70.1 [6.7] years; 168 [57.7%] female; 7 [2.4%] Asian, 32 [11.0%] Black, 3 [1.0%] Pacific Islander, 241 [82.8%] White, 6 [2.1%] multiracial, and 2 [0.7%] unknown), 156 were randomized to CBT-I and 135 to SET. A total of 140 participants (89.7%) completed CBT-I and 130 (96.3%) participants completed SET (χ2 = 4.9, P = .03), with 114 (73.1%) completing 24 months of follow-up in the CBT-I group and 117 (86.7%) in the SET group (χ2 = 8.4, P = .004). After protocol modification, 92 (59.0%) of the CBT-I participants and 86 (63.7%) of the SET participants agreed to extended follow-up (χ2 = 0.7, P = .41), with 81 (51.9%) of the CBT-I participants and 77 (57.0%) of the SET group completing 36 months of follow-up (χ2 = 0.8; P = .39). Incident or recurrent major depression occurred in 19 participants (12.2%) in the CBT-I group and in 35 participants (25.9%) in the SET group, with an overall benefit (hazard ratio, 0.51; 95%, CI 0.29-0.88; P = .02) consistent across subgroups. Remission of insomnia disorder continuously sustained before depression event or during follow-up was more likely in CBT-I participants (41 [26.3%]) compared with the SET participants (26 [19.3%], P = .03). Those in the CBT-I group with sustained remission of insomnia disorder had an 82.6% decreased likelihood of depression (hazard ratio, 0.17; 95%, CI 0.04-0.73; P = .02) compared with those in the SET group without sustained remission of insomnia disorder.
Conclusions and relevance
The findings of this randomized clinical trial indicate that treatment of insomnia with CBT-I has an overall benefit in the prevention of incident and recurrent major depression in older adults with insomnia disorder. Community-level screening for insomnia concerns in older adults and wide delivery of CBT-I-based treatment for insomnia could substantially advance public health efforts to treat insomnia and prevent depression in this vulnerable older adult population.
Trial registration
ClinicalTrials.gov Identifier: NCT01641263.
Fuentes y atribución
Prevention of Incident and Recurrent Major Depression in Older Adults With Insomnia: A Randomized Clinical Trial.
Irwin MR, Carrillo C, Sadeghi N, Bjurstrom MF, Breen EC, Olmstead R.
JAMA psychiatry · 2022-01-01
DOI: 10.1001/jamapsychiatry.2021.3422 ↗PubMed · 34817561 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Exercise improved sleep-quality scores in adults 45 and older with sleep disorders
Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.
Journal of Exercise Science & Fitness
Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults
Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.
Sleep
Sleep extension cut daily energy intake by about 270 kcal in adults with overweight
In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.
JAMA Internal Medicine
Six hours or less of sleep at 50 and 60 linked to higher dementia risk
In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.
Nature Communications

